Concepedia

Yazmín Odia

YO

37

Publications

2K

Citations

22

H-Index

2010

Active since

Affiliations

Baptist Health South Florida(Current)

Baptist Hospital of Miami

Florida International University

University of California, San Francisco

Oncoceutics (United States)

Yazmín Odia is an author at Baptist Health South Florida specializing in neuro-oncology, medicine, and glioma.

ORCID

Top concepts

Publications per year

2010–2025

37

Publications

37

Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201

S. Andrew, Rohinton S. Tarapore, Matthew D. Hall et al. · Journal of Neuro-Oncology · 2019 · 187 citations

, , +8

Yes-Associated Protein 1 Is Widely Expressed in Human Brain Tumors and Promotes Glioblastoma Growth

Brent A. Orr, Haibo Bai, Yazmín Odia et al. · Journal of Neuropathology & Experimental Neurology · 2011 · 164 citations · Full text

, , +15

Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji et al. · Cancer Discovery · 2023 · 130 citations · Full text

A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma

Teri Kreisl, Wei Zhang, Yazmín Odia et al. · Neuro-Oncology · 2011 · 115 citations · Full text

Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma

Evan Cantor, Kyle Wierzbicki, Rohinton S. Tarapore et al. · Neuro-Oncology · 2022 · 108 citations · Full text

Rows per page

1–5 of 37